使用代谢工程Escherichia coli的高效生产5-hydroxyectoine
Zhijie Qin1, Lihong Li2, Weizhu Zeng2
1National Engineering Research Center of Cereal Fermentation and Food Biomanufacturing, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu 214122, China; Science Center for Future Foods, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu 214122, China; Engineering Research Center of Ministry of Education on Food Synthetic Biotechnology, School of Biotechnology, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu 214122, China.
Bioresource technology
|September 16, 2024
概括
研究人员对大肠杆菌 (大肠杆菌) 进行了基因工程设计,以产生5-hydroxyectoine,这是一种天然保湿剂和辐射保护剂. 这种优化的微生物菌株在一种新的低盐发酵过程中实现了创纪录的58g/L产量.
科学领域:
- 生物技术是生物技术.
- 微生物工程 微生物工程
- 生物化学生产 生化生产
背景情况:
- 5-氧乙提供显著的保湿和抗辐射的好处.
- 通过细菌奶,极端动物的自然生产受到生物反应器腐蚀和环境污染的限制.
- 开发可持续和高效的微生物生产方法对5-基叶至关重要.
研究的目的:
- 为了设计一个强大的大肠杆菌 (E. coli) 菌株,以生产高产的5-基叶.
- 为了优化发酵条件,增加5-氧胺位.
- 建立一个可扩展和环保的生产过程.
主要方法:
- 乙酸酶的表征,以确定最有效的酶 (来自Halomonas elongata).
- 在大肠杆菌中引入一个L-2,4-diaminobutyrate转氨酶突变体.
- 代谢工程策略包括氧酸盐循环激活和α-谷氨酸平衡.
- 在没有NaCl的介质中优化半连续养过程.
主要成果:
- 工程E.大肠杆菌在摇瓶中积累了2.8g/L的5-氧乙.
- 代谢优化将标位提高到3.4g/L.
- 在没有NaCl的介质中使用半连续养过程获得了58g/L的最终产量5-hydroxyectoine,这代表了E. coli报告的最高标位.
结论:
- 成功设计了大肠杆菌,用于高位数的5-氧乙合成.
- 建立了一个新的低盐发酵工艺,克服了传统方法的局限性.
- 这项工作为可持续和高效的工业生产提供了基础. 5-氧乙.
相关概念视频
Bioreactor Controls-III
55
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
55
Upstream Processing
87
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
87
Production of Pharmaceuticals
70
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
70


